Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long-Lasting Effects of Methocinnamox on Opioid Self-Administration in Rhesus Monkeys
David R. Maguire, Lisa R. Gerak, James H. Woods, et al.
Journal of Pharmacology and Experimental Therapeutics (2018) Vol. 368, Iss. 1, pp. 88-99
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Conjugate vaccine produces long-lasting attenuation of fentanyl vs. food choice and blocks expression of opioid withdrawal-induced increases in fentanyl choice in rats
E. Andrew Townsend, Steven Blake, Kaycee E. Faunce, et al.
Neuropsychopharmacology (2019) Vol. 44, Iss. 10, pp. 1681-1689
Open Access | Times Cited: 64
Countermeasures for Preventing and Treating Opioid Overdose
Charles P. France, Gerard P. Ahern, Saadyah Averick, et al.
Clinical Pharmacology & Therapeutics (2020) Vol. 109, Iss. 3, pp. 578-590
Open Access | Times Cited: 54
Targeting Opioid Receptors in Addiction and Drug Withdrawal: Where Are We Going?
Rita Tabanelli, Simone Brogi, Vincenzo Calderone
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10888-10888
Open Access | Times Cited: 11
Lorcaserin maintenance fails to attenuate heroin vs. food choice in rhesus monkeys
E. Andrew Townsend, S. Stevens Negus, Justin L. Poklis, et al.
Drug and Alcohol Dependence (2020) Vol. 208, pp. 107848-107848
Open Access | Times Cited: 30
National Institutes of Health (NIH) Executive Meeting Summary: Developing Medical Countermeasures to Rescue Opioid-Induced Respiratory Depression (a Trans-Agency Scientific Meeting)—August 6/7, 2019
David T. Yeung, Kristopher J. Bough, Jill R. Harper, et al.
Journal of Medical Toxicology (2019) Vol. 16, Iss. 1, pp. 87-105
Open Access | Times Cited: 22
Medications Development for Treatment of Opioid Use Disorder
E. Andrew Townsend, S. Stevens Negus, Matthew L. Banks
Cold Spring Harbor Perspectives in Medicine (2020) Vol. 11, Iss. 1, pp. a039263-a039263
Open Access | Times Cited: 20
Effects of acute and repeated treatment with methocinnamox, a mu opioid receptor antagonist, on fentanyl self-administration in rhesus monkeys
David R. Maguire, Lisa R. Gerak, Jesus J. Sanchez, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 12, pp. 1986-1993
Open Access | Times Cited: 20
Methocinnamox Reverses and Prevents Fentanyl-Induced Ventilatory Depression in Rats
Víctor Jiménez, Gabriel Castaneda, Charles P. France
Journal of Pharmacology and Experimental Therapeutics (2021) Vol. 377, Iss. 1, pp. 29-38
Open Access | Times Cited: 18
Effects of Daily Methocinnamox Treatment on Fentanyl Self-Administration in Rhesus Monkeys
David R. Maguire, Charles P. France
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 382, Iss. 2, pp. 181-187
Open Access | Times Cited: 12
Methocinnamox Produces Long-Lasting Antagonism of the Behavioral Effects of µ-Opioid Receptor Agonists but Not Prolonged Precipitated Withdrawal in Rats
Lisa R. Gerak, Vanessa Minervini, Elizabeth A Latham, et al.
Journal of Pharmacology and Experimental Therapeutics (2019) Vol. 371, Iss. 2, pp. 507-516
Open Access | Times Cited: 18
Long‐term antagonism and allosteric regulation of mu opioid receptors by the novel ligand, methocinnamox
Joshua C. Zamora, Hudson R. Smith, Elaine M. Jennings, et al.
Pharmacology Research & Perspectives (2021) Vol. 9, Iss. 6
Open Access | Times Cited: 16
Behavioral pharmacology of methocinnamox: A potential new treatment for opioid overdose and opioid use disorder
David R. Maguire, Charles P. France
Journal of the Experimental Analysis of Behavior (2023) Vol. 119, Iss. 2, pp. 392-406
Open Access | Times Cited: 5
Translational value of non-human primates in opioid research
Huiping Ding, Mei‐Chuan Ko
Experimental Neurology (2021) Vol. 338, pp. 113602-113602
Open Access | Times Cited: 12
Pharmacologic profile of ITI-333: a novel molecule for treatment of substance use disorders
Gretchen L. Snyder, Peng Li, Terry Martin, et al.
Psychopharmacology (2024) Vol. 241, Iss. 7, pp. 1477-1490
Open Access | Times Cited: 1
OREX-1019: A Novel Treatment of Opioid Use Disorder and Relapse Prevention
David R. Maguire, Lisa R. Gerak, Gerta Cami‐Kobeci, et al.
Journal of Pharmacology and Experimental Therapeutics (2019) Vol. 372, Iss. 2, pp. 205-215
Open Access | Times Cited: 12
The Potential of Methocinnamox as a Future Treatment for Opioid Use Disorder: A Narrative Review
Colleen Jordan, Amy L. Kennalley, Alivia L. Roberts, et al.
Pharmacy (2022) Vol. 10, Iss. 3, pp. 48-48
Open Access | Times Cited: 7
Effects of 2,5-Dimethoxy-4-Methylamphetamine (DOM) and 2-Piperazin-1-yl-Quinoline (Quipazine) on Fentanyl Versus Food Choice in Rhesus Monkeys
David R. Maguire
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 384, Iss. 1, pp. 155-162
Closed Access | Times Cited: 7
Methocinnamox (MCAM) antagonizes the behavioral suppressant effects of morphine without impairing delayed matching-to-sample accuracy in rhesus monkeys
Vanessa Minervini, Alex Disney, Stephen M. Husbands, et al.
Psychopharmacology (2020) Vol. 237, Iss. 10, pp. 3057-3065
Open Access | Times Cited: 10
Interactions between opioids and stimulants: Behavioral pharmacology of abuse-related effects
David R. Maguire, Vanessa Minervini
Advances in pharmacology (2022), pp. 1-33
Closed Access | Times Cited: 6
Attenuation of the Positive-Reinforcing Effects of Ultra-Potent Fentanyl Analogs, Along with Those of Fentanyl and Heroin, During Daily Treatment with Methocinnamox in Rhesus Monkeys
Lisa R. Gerak, Charles P. France
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 384, Iss. 3, pp. 363-371
Closed Access | Times Cited: 6
Daily methocinnamox treatment dose-dependently attenuates fentanyl self-administration in rhesus monkeys
David R. Maguire, Charles P. France
Neuropharmacology (2023) Vol. 243, pp. 109777-109777
Open Access | Times Cited: 3
Behavioral Pharmacology of Drugs Acting at Mu Opioid Receptors
Lisa R. Gerak, David R. Maguire, Charles P. France
Handbook of experimental pharmacology (2019), pp. 127-145
Closed Access | Times Cited: 8
Effects of buprenorphine/lorcaserin mixtures on preference for heroin, cocaine, or saline over food using a concurrent choice procedure in rhesus monkeys
Lisa R. Gerak, Charles P. France
Drug and Alcohol Dependence (2021) Vol. 227, pp. 108991-108991
Open Access | Times Cited: 7
Neural circuits controlling choice behavior in opioid addiction
Victoria N. Chang, Jamie Peters
Neuropharmacology (2022) Vol. 226, pp. 109407-109407
Open Access | Times Cited: 5
Interactions between opioids and cannabinoids: Economic demand for opioid/cannabinoid mixtures
David R. Maguire, Charles P. France
Drug and Alcohol Dependence (2020) Vol. 212, pp. 108043-108043
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top